Skip to main content
eScholarship
Open Access Publications from the University of California

NELL-1 in the treatment of osteoporotic bone loss

  • Author(s): James, AW
  • Shen, J
  • Zhang, X
  • Asatrian, G
  • Goyal, R
  • Kwak, JH
  • Jiang, L
  • Bengs, B
  • Culiat, CT
  • Turner, AS
  • Seim, HB
  • Wu, BM
  • Lyons, K
  • Adams, JS
  • Ting, K
  • Soo, C
  • et al.
Abstract

© 2015 Macmillan Publishers Limited. All rights reserved. NELL-1 is a secreted, osteoinductive protein whose expression rheostatically controls skeletal ossification. Overexpression of NELL-1 results in craniosynostosis in humans and mice, whereas lack of Nell-1 expression is associated with skeletal undermineralization. Here we show that Nell-1-haploinsufficient mice have normal skeletal development but undergo age-related osteoporosis, characterized by a reduction in osteoblast:osteoclast (OB:OC) ratio and increased bone fragility. Recombinant NELL-1 binds to integrin β1 and consequently induces Wnt/β-catenin signalling, associated with increased OB differentiation and inhibition of OC-directed bone resorption. Systemic delivery of NELL-1 to mice with gonadectomy-induced osteoporosis results in improved bone mineral density. When extended to a large animal model, local delivery of NELL-1 to osteoporotic sheep spine leads to significant increase in bone formation. Altogether, these findings suggest that NELL-1 deficiency plays a role in osteoporosis and demonstrate the potential utility of NELL-1 as a combination anabolic/antiosteoclastic therapeutic for bone loss.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View